SCHEMBL24029587

SCHEMBL24029587

C#CCN(C)CCNC(=O)C(C)(C)N

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.34
PYCR1 P32322 1/20 0.33
ACHE P22303 1/20 0.32
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26550945 0.87 MAOB (0.35) MAOBPYCR1ACHEKDM1A
SCHEMBL24029756 0.86
SCHEMBL26806264 0.84 DPP4 (0.38)
SCHEMBL8936036 0.78 MAOB (0.38) MAOBPYCR1ACHEKDM1A
SCHEMBL15741039 0.77 DNM1 (0.42)
SCHEMBL3250569 0.76 TDP1 (0.45) MAOB
SCHEMBL26570547 0.76 TDP1 (0.36) MAOB
Hydrochloric Acid SCHEMBL21197522 0.75 DNM1 (0.41)
SCHEMBL24029929 0.75
SCHEMBL24029773 0.75 MAOB (0.36) MAOBPYCR1ACHEKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423775-B Aryl glucoside derivative, and preparation method and application thereof 上海喆邺生物科技有限公司 2024-11-22 CN disclosed
US-20230365610-A1 Aryl Glucoside Derivative SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2023-11-16 US disclosed
US-20230365610-A1 Aryl Glucoside Derivative SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2023-11-16 US disclosed
US-20230331760-A1 ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2023-10-19 US disclosed
US-20230331760-A1 ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2023-10-19 US disclosed
US-20230331761-A1 Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2023-10-19 US disclosed
US-20230331761-A1 Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2023-10-19 US disclosed
CN-115003661-B Aryl glucoside derivative and application thereof in medicines 上海喆邺生物科技有限公司 2023-05-30 CN disclosed
CN-114599643-B Aryl glucoside derivative 上海喆邺生物科技有限公司 2023-04-14 CN disclosed
CN-115003661-A Aryl glucoside derivatives and their use in medicine 上海喆邺生物科技有限公司 2022-09-02 CN disclosed
CN-114599643-A Aryl glucoside derivative 上海喆邺生物科技有限公司 2022-06-07 CN disclosed
CN-114423775-A Aryl glucoside derivatives, and preparation method and application thereof 上海喆邺生物科技有限公司 2022-04-29 CN disclosed
WO-2021227439-A1 ARYL GLUCOSIDE DERIVATIVE 上海喆邺生物科技有限公司 2021-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331761-A1 Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof SLC5A1, SLC5A2, SLC10A1 MAOB 1445/4885PYCR1 1632/4885ACHE 3415/4885
US-20230331760-A1 ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG SLC5A1, SLC5A2, SLC10A1 MAOB 1605/4885PYCR1 1592/4885ACHE 4357/4885
US-20230365610-A1 Aryl Glucoside Derivative SLC5A1, SLC5A2, SLC10A1 MAOB 1156/4885PYCR1 1607/4885ACHE 3467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.